Healthcare ❯ Pharmaceuticals ❯ Drug Approval

FDA Regulations

Clinical Trials Clinical Research Wegovy Medication Access Off-Label Use Chronic Kidney Disease Hypertension Treatments Leqembi Addyi

Shareholder Law Firms Expand Probes of Corcept After FDA CRL for Relacorilant

The agency said it needs additional evidence of effectiveness before assessing the drug for hypertension tied to hypercortisolism.

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65